US accuses Chinese AI firms of 'malicious' copying of AI technology - reuters.com

The United States has formally accused several Chinese artificial‑intelligence companies of engaging in “malicious” copying of proprietary AI technology developed by American firms. The allegations were announced by officials from the U.S. Commerce Department, who said the Chinese firms had systematically appropriated trade secrets and other confidential information to accelerate their own AI products.

According to the complaint, the targeted companies include prominent Chinese technology firms that have rapidly expanded their AI offerings in recent years. U.S. authorities claim the firms obtained the stolen data through illicit means, such as hacking, insider theft, and the use of front‑company networks designed to conceal the origin of the copied material. The copied technology is said to encompass large language models, training data sets, and specialized algorithms that underpin advanced generative AI services.

The United States is seeking to impose export controls and other trade restrictions on the implicated Chinese entities, arguing that the alleged misconduct undermines fair competition and poses a national‑security risk. The measures could limit the ability of the Chinese firms to access U.S. semiconductor components, cloud services, and other critical inputs required for AI development.

Chinese officials have not yet issued a detailed response to the specific accusations, but they have previously defended the country’s AI sector as operating within international legal norms. The Chinese government has emphasized its commitment to protecting intellectual property and has warned that any unilateral actions by the United States could damage bilateral trade relations.

The dispute comes amid a broader global debate over AI governance, intellectual‑property protection, and the competitive dynamics between the United States and China in emerging technologies. Both sides are expected to continue diplomatic and legal engagements as the case proceeds through U.S. regulatory channels.